How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Dr. Tobias Bexte will share recent advances that overcome key barriers to making NK cell therapies safe, effective and widely ...

Prof. Lukas Dow, biochemistry, and his team published a study in Nature on Aug. 16, detailing a new, more specific gene editing tool that they created to study cancer mutations through preclinical ...

They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...

Unlocking secrets from East Africa's naked mole rats, scientists are amazed by their cancer immunity and unique social ...

Cemacabtagene ansegedleucel, an allogeneic chimeric antigen receptor (CAR) T-cell therapy, is being investigated in relapsed/refractory large B-cell lymphoma. The investigational allogeneic chimeric ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer. (Nanowerk Spotlight) Immune-based cancer ...

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

Researchers at the Centre for Genomic Regulation show that cancer doesn’t invent new tricks—it reawakens embryonic splicing ...